Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111770917B details a novel asymmetric route for Factor XIa inhibitor intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102643236A details a green synthesis of chiral imidazolium ionic liquids from natural amino acids, offering high purity and cost-effective manufacturing solutions.
Patent CN109053526A details efficient synthesis. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Patent CN104478791A details asymmetric synthesis for Ledipasvir intermediate, ensuring high purity and cost efficiency without chiral resolution steps.
Novel chiral synthesis of Rasagiline Mesylate from 1-indanone. High yield, low cost, industrial scale-up ready for Parkinson's API intermediates.
Patent CN101935309B reveals a high-yield route for ezetimibe intermediates using a tricyclic indene oxazole auxiliary, offering superior stereoselectivity and cost-effective manufacturing solutions.
Patent CN1978442A details a novel mannitol-based route for Nepyrrolol HCl, offering improved purity and scalability for reliable pharmaceutical intermediate suppliers.
Patent CN115806510B reveals a cost-effective two-step synthesis for high-purity Cariprazine intermediates, offering significant supply chain advantages for API manufacturers.
Novel low-cost route for Sitagliptin intermediates via chiral resolution. Reduces catalyst costs and simplifies scale-up for API manufacturing.
Patent CN104761465A reveals a novel route for lacosamide intermediates ensuring high purity and simplified supply chain for global pharmaceutical manufacturing partners.
Patent CN103435532A details a low-cost synthesis of Boceprevir intermediates. Discover how this novel route eliminates precious metal catalysts for superior supply chain reliability.
Novel synthesis route for esomeprazole intermediates via patent CN104098515B. Offers high yield, purity, and scalable production for global supply chains.
Patent CN115490732B discloses a novel one-pot synthesis for chiral biphenyl diol selenium sulfide catalysts offering mild conditions and cost-effective manufacturing for fine chemical intermediates.
Patent CN107304179B details a novel synthesis for LCZ696 intermediates featuring improved stereocontrol and yield. Ideal for reliable pharmaceutical intermediate suppliers seeking scalable routes.
Patent CN115417783A details a novel route for oseltamivir enantiomers, offering high purity and scalable manufacturing for global antiviral supply chains.
Patent CN101100428A details a green boric acid-catalyzed route for high-purity chiral diethyl tartrate, offering cost reduction and zero-discharge manufacturing for pharma intermediates.
Discover the novel chiral reduction method for L-phenylephrine hydrochloride production. This patent-based analysis highlights cost-effective manufacturing and high-purity supply chain solutions.
Patent CN116425760B details a novel rhodium-catalyzed route for chiral cephalotaxine. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN105330608A reveals high-ee urazole synthesis. Enables cost reduction in chiral catalyst manufacturing and reliable supply chain for pharma intermediates.
Patent CN116178153A discloses novel monodentate phosphine ligands enabling high-yield, high-ee palladium-catalyzed Tsuji-Trost reactions for cost-effective pharmaceutical intermediate manufacturing.